BGI

History

YearDetail
1999 BGI was established for the Human Genome Project.
2000 BGI signed the Agreement on the Development of China's Super Hybrid Rice Genome Research. The rice genome project was launched.
2003 BGI revealed the whole genome sequence of four SARS virus strains for the first time in China. 
2007 Shenzhen BGI Research Institute (currently BGI-Research) was established.
2010 BGI-Research, Sanger Institute, and the National Human Genome Research Institute launched the 1000 Genomes Project. 
2014 BGI worked with other institutions to develop the Ebola virus nucleic acid detection reagent successfully. BGI teamed up with scientists from over 20 countries to complete the large-scale bird genome project.
2015 BGISEQ-500, the first proprietary desktop high-throughput sequencing system, was launched globally.
2016 BGISEQ-50, a proprietary high-throughput desktop sequencing system, was launched globally.
2019 BGI launched the research result of the world's largest genome set of human intestinal bacteria.
2020 BGI Genomics developed the SARS-CoV-2 nucleic acid testing kits. BGI-Research to operate Shenzhen BGI Hospital, a major health project in Shenzhen, and positioned as a municipal public hospital.
2021 BGI-Research Sanya was unveiled, and six units collaborated to create a global big data center for zoology and botany.
2022 BGI Australia's lab has achieved accreditation from the National Association of Testing Authorities (NATA) to perform clinical Whole Exome Sequencing in Australia.